{
    "title": "Seattle Genetics and Takeda's cancer drug meets main trial goal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2773630/Seattle-Genetics-Takedas-cancer-drug-meets-main-trial-goal.html",
    "date": "2014-09-29",
    "keywords": [
        "drug",
        "trial",
        "cancer",
        "gmt",
        "september",
        "therapy",
        "latestage",
        "type",
        "adcetris",
        "cell",
        "placebo",
        "marketing",
        "goal",
        "email",
        "inc",
        "co",
        "ltd",
        "consolidation",
        "cancerconsolidation",
        "body",
        "stem",
        "transplant",
        "disease",
        "statementthe",
        "stage",
        "risk",
        "relapse",
        "lymphomaseattle",
        "application",
        "use",
        "europe",
        "takeda",
        "market",
        "rest",
        "worldadcetris",
        "treatment",
        "hodgkin",
        "lymphoma",
        "percent",
        "premarket",
        "trading",
        "nasdaq",
        "reporting",
        "rao",
        "koppala",
        "bangalore",
        "editing",
        "dsouza"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}